Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Week In Review: $1.7 Billion Collaboration Between Elpiscience And Astellas Is Final 2023 Deal By: TalkMarkets December 31, 2023 at 11:00 AM EST Shanghai’s Elpiscience Biopharma has formed a $1.7 billion collaboration with Japan’s Astellas Pharma to develop a novel bispecific macrophage engager, ES019, along with an unspecified program. Initially, Elpiscience will receive up to $37 million. Read More >> Related Stocks: Astellas Pharma Inc Astrazeneca Plc ADR Gracell Biotechnologies Inc ADR Innovent Biologics Inc Lianbio ADR Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Week In Review: $1.7 Billion Collaboration Between Elpiscience And Astellas Is Final 2023 Deal By: TalkMarkets December 31, 2023 at 11:00 AM EST Shanghai’s Elpiscience Biopharma has formed a $1.7 billion collaboration with Japan’s Astellas Pharma to develop a novel bispecific macrophage engager, ES019, along with an unspecified program. Initially, Elpiscience will receive up to $37 million. Read More >> Related Stocks: Astellas Pharma Inc Astrazeneca Plc ADR Gracell Biotechnologies Inc ADR Innovent Biologics Inc Lianbio ADR